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Friendly neighbours feed tumour cells  
 
In pancreatic cancer, neighbouring non-cancerous cells degrade their own proteins 
through a process called autophagy and release amino acids that are then taken up and 
used by the cancer cells 
 
JURRE J. KAMPHORST & EYAL GOTTLIEB  
 
The cancer pancreatic ductal adenocarcinoma (PDAC) has a poor prognosis, and is an area of 
intense biomedical research. Previous studies
1,2
 have shown that PDAC has a growth-
promoting effect on pancreatic stellate cells in the surrounding connective tissue, and these 
cells reciprocate by supporting tumour growth and spread. On page 479, Sousa et al.
3
 
investigate the possibility that pancreatic stellate cells directly provide tumour cells with 
nutrients, in studies using mice and human pancreatic cells.  
A key feature of PDAC is desmoplasia, in which the tumour becomes enmeshed and 
surrounded by dense, scar-like tissue
1,4
. As well as the tumour cells, desmoplasia involves 
other cell types, including pancreatic stellate cells, which are mainly responsible for the 
condition, and immune cells. Desmoplasia is a serious medical concern, because it forms a 
barrier to treatment with chemotherapeutic drugs as a result of poor blood perfusion into the 
tumour
5
. Paradoxically, desmoplasia is promoted by the release of signalling factors by the 
tumour, even though it also impedes the tumour’s blood supply and hence its access to 
oxygen, glucose and other nutrients.  
How can tumour cells obtain sufficient food and energy in the resulting nutrient poor 
conditions? Sousa et al. showed that when PDAC cells were grown in vitro with either 
pancreatic stellate cells or even in the solution in which the stellate cells had been previously 
grown, oxygen consumption by the PDAC cells increased. This indicates that factors from 
the stellate cells can stimulate the activity of energy-producing organelles called 
mitochondria. Sousa and colleagues found that the increased mitochondrial activity is due to 
tumour consumption of the amino acid alanine, which is released at a high rate by the stellate 
cells.  
The authors used alanine labelled with heavy carbon isotopes to trace the fate of this 
imported amino acid in tumour cells. Surprisingly, they found that alanine had an unusual 
metabolic fate in PDAC cells beyond its normal role in protein synthesis. When taken up by 
the cells, alanine can be metabolized to pyruvate in the aqueous intracellular region known as 
the cytosol. However, the authors found that instead it went primarily into the mitochondrial 
pool of metabolite molecules (Fig. 1).  
Pyruvate is a key molecule in the mitochondrial tricarboxylic acid cycle, which 
generates cellular energy and feeds into biosynthetic pathways such as lipid synthesis. It is 
usually generated by glucose metabolism in a process called glycolysis. Another potential 
source of pyruvate is alanine transamination, in which pyruvate is produced by the removal 
of nitrogen from alanine. Alanine transamination can occur in the cytosol or the 
mitochondria. 
Sousa et al. found that the alanine supplied to pancreatic cancer cells undergoes 
transamination primarily in the mitochondria, producing pyruvate that enters the tricarboxylic 
acid cycle to provide the cells with energy and lipid molecules. Such selective channelling of 
alanine to these biosynthetic pathways frees up glucose in the cell for use in other roles, such 
as production of the amino acid serine, which is required for nucleic-acid biosynthesis and 
hence cell growth and division.  
Although Sousa and colleagues’ work documents the metabolic support that alanine 
from pancreatic stellate cells can offer PDAC cells, it is unclear how and why alanine is 
channelled specifically to mitochondria. Alanine-derived pyruvate in the cytosol can also be 
transported to mitochondria for energy and biosynthesis purposes, and yet this takes place to 
a lesser degree. Direct transamination of alanine to pyruvate in the mitochondria seals its 
metabolic fate as a source of energy or biosynthetic molecules. One possible explanation for 
this compartmentalization of alanine transamination is the potentially higher availability of 
the nitrogen-acceptor molecule α-ketoglutarate in the mitochondria, which might enable fast 
and efficient production of pyruvate in response to the large supply of alanine from stellate 
cells.  
Sousa et al. made a surprising finding — that a process called autophagy could affect 
a neighbouring cell. Autophagy is a survival mechanism used by cells to break down and 
metabolize their expendable proteins, lipids and other macromolecules when nutrients are 
scarce. It has been considered to be a process that acts only in the cell itself. However, Sousa 
and colleagues demonstrated that inhibiting autophagy in pancreatic stellate cells did not 
affect the cells’ growth, but rather abolished alanine release and the resulting support of 
PDAC-cell growth both in vitro and in vivo (when PDAC cells and pancreatic stellate cells 
were transplanted together into mice).  
The metabolic support of tumour cells by autophagy in pancreatic stellate cells 
provides a twist to the emerging tale of metabolic scavenging by PDAC cells. These latter 
cells have a high basal autophagy rate, helping them to survive metabolic hardship
6,7
. The 
previous observation
8
 that PDAC-cell scavenging of extracellular proteins such as albumin 
can support PDAC metabolism and growth in nutrient-limited conditions highlights the 
tendency of these cancer cells to exploit diverse nutrient sources. Extracellular material is 
taken up by the cell through macropinocytosis, a cell-membrane-based transport system. 
These uptake and autophagy processes depend on organelles called lysosomes, and lysosomal 
activity was recently found
9
 to be increased in PDAC.  
Sousa and colleagues’ work provides metabolic insight into the well-documented 
crosstalk between cancer cells and their neighbours. It has been demonstrated
10
 that 
pancreatic cancer cells send signals to adjacent stellate cells that then reciprocate and alter the 
intracellular signalling and metabolism of the cancer cells. It will be interesting to learn 
which tumour-generated signals stimulate autophagy and alanine secretion from the 
pancreatic stellate cells.  
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Figure 1 | Pancreatic stellate cells feed a tumour. Pancreatic ductal adenocarcinoma is a form 
of pancreatic cancer that is characterized by the build-up of dense, scar-like tissue pervading 
the tumour. This limits the delivery of oxygen and nutrients (including glucose) to the tumour 
cells by blood vessels. Sousa et al.
3
 find that, near tumour cells, pancreatic stellate cells 
degrade their own proteins in a process called autophagy and release the resulting amino 
acids, most notably alanine, which are taken up and consumed by the tumour cells, 
facilitating cancer growth. In the tumour cell, alanine is metabolized to produce pyruvate in 
organelles called mitochondria, where pyruvate is used to produce energy and lipids through 
the tricarboxylic acid (TCA) cycle. The use of this pyruvate generated from alanine allows 
the limited glucose in the cell to be used for other metabolic purposes. 
